Nilesh B. Ingle

212/2, Off Soli Poonawalla Road, Hadapsar
Pune, MH 411028, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Plaque reduction neutralization test (PRNT50) for the detection of anti-yellow fever antibodies from clinical samples.

Plaque reduction neutralization test (PRNT50) for the detection of anti-yellow fever antibodies from clinical samples.

Journal: Vaccine
Published: October 25, 2025

Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats.

Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats.

Journal: Vaccine
Published: July 28, 2025

Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates.

Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates.

Journal: Vaccine
Published: December 11, 2021

Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform.

Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform.

Journal: Vaccine
Published: June 19, 2020

Detection of human parvovirus 4 DNA in the patients with acute encephalitis syndrome during seasonal outbreaks of the disease in Gorakhpur, India.

Detection of human parvovirus 4 DNA in the patients with acute encephalitis syndrome during seasonal outbreaks of the disease in Gorakhpur, India.

Journal: Emerging microbes & infections
Published: March 15, 2019

Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.

Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.

Journal: Vaccine
Published: May 28, 2018

Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response.

Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response.

Journal: Frontiers in immunology
Published: August 31, 2016

Evaluation of Liposome, Heat-Killed Mycobacterium w, and Alum Adjuvants in the Protection Offered by Different Combinations of Recombinant HA, NP proteins, and M2e Against Homologous H5N1 Virus.

Evaluation of Liposome, Heat-Killed Mycobacterium w, and Alum Adjuvants in the Protection Offered by Different Combinations of Recombinant HA, NP proteins, and M2e Against Homologous H5N1 Virus.

Journal: Viral immunology
Published: August 11, 2016
Showing 1-8 of 8

Last Updated: 09/26/2026